Cannabis Laws in Japan

Legal framework

Cannabis in Japan is regulated under the Cannabis Control Act (大麻取締法, Taima Torishimari Hō), enacted in 1948 during the Allied occupation ^[1][2]. The law prohibits possession, cultivation, transfer, import, and export of cannabis without a license. Licenses historically have been issued almost exclusively to a small number of traditional hemp farmers (for ritual and textile use) and to researchers ^[2].

A parallel regime, the Narcotics and Psychotropics Control Act, governs synthetic cannabinoids and isolated THC. A 2023 amendment package, which took effect in December 2024, restructured how cannabis is treated — most significantly by criminalizing use itself, which had not previously been a crime under the Cannabis Control Act ^[3][4].

Penalties

Penalties under the amended Cannabis Control Act are severe by international standards ^[3][4]:

• Possession, receipt, or use (non-commercial): up to 7 years imprisonment.
• Possession or use for profit: up to 10 years imprisonment plus a fine of up to ¥3,000,000.
• Cultivation, import, export, transfer (non-commercial): up to 7 years.
• Cultivation, import, export, transfer for profit: up to 10 years plus a fine of up to ¥3,000,000.

Japanese prosecutors decline to indict in some first-time, small-quantity cases, but the conviction rate for cases that go to trial exceeds 99% ^[5]. Suspended sentences are common for first offenses involving small amounts, but pre-trial detention (up to 23 days without charge) is standard ^[5][6]. Foreign nationals convicted of drug offenses are typically deported and barred from re-entry.

The 2023 reform: medical access and the new use offense

In December 2023, the Diet passed amendments to the Cannabis Control Act and the Narcotics and Psychotropics Control Act. The changes, which took full effect on December 12, 2024, did two things ^[3][4]:

1. Permitted cannabis-derived medicines to be prescribed and imported through the standard pharmaceutical approval pathway. This enabled the approval of Epidiolex (cannabidiol) for rare pediatric epilepsies — the first cannabis-derived prescription drug legally available in Japan ^[4][7]. This is not a broad medical cannabis program; there is no dispensary system, no patient cultivation, and no access to THC products.
2. Criminalized use of cannabis. Previously, only possession and cultivation were offenses — a quirk that had been justified historically as protecting licensed hemp farmers from accidental exposure. The new use offense carries the same maximum penalties as possession ^[3].

The practical effect is that hair and urine testing can now be used as standalone evidence of an offense, including for Japanese nationals who consumed cannabis legally abroad and returned to Japan, though enforcement of the extraterritorial dimension remains an open question ^[3][8]. Weak / limited

CBD and hemp products

CBD is legal in Japan when it meets strict conditions ^[9]:

• It must be derived from the mature stalks or seeds of the cannabis plant (the parts excluded from the Cannabis Control Act's definition of "cannabis").
• It must contain no detectable THC. Japan does not use the 0.2% or 0.3% THC threshold seen in the EU or US — the standard has effectively been zero ^[9][10].
• Imports require documentation proving the source plant parts and THC-free status; customs routinely seizes non-compliant products.

Under the 2024 amendments, Japan is moving toward a residual-THC limit framework similar to other jurisdictions, with specific ppm thresholds for different product categories (oils, foods, cosmetics) set by ministerial ordinance ^[4][9]. Operators selling CBD in Japan should consult current Ministry of Health, Labour and Welfare (MHLW) guidance, which has been updated multiple times. Strong evidence

Enforcement patterns and foreign nationals

Cannabis arrests in Japan have risen sharply over the past decade. The National Police Agency reported over 6,700 cannabis-related arrests in 2023, a record high, with people in their 20s and teenagers making up the largest share ^[11]. Methamphetamine arrests, historically Japan's dominant drug offense, have declined in the same period.

For foreign visitors and residents:

• Bringing any cannabis product — including CBD gummies, vape cartridges, or edibles purchased legally abroad — into Japan can result in arrest at customs.
• Embassies (including the US and UK) explicitly warn travelers that products legal at origin are not legal in Japan ^[12].
• Detention conditions during the pre-charge 23-day period are demanding: limited consular access, interrogation without an attorney present, and no bail until indictment ^[5][6].

High-profile cases involving Japanese celebrities, athletes, and university students are reported frequently in domestic media and tend to end careers regardless of legal outcome.

Cultural and historical context

Cannabis (taima or asa) has a long history in Japan as a fiber crop and as a ritual plant in Shinto practice — hemp rope (shimenawa) still marks sacred spaces at shrines ^[2][13]. Prohibition was not a domestic policy choice but was imposed during the 1945–1952 Allied occupation and codified in the 1948 Cannabis Control Act ^[1][2].

This history matters because public attitudes have remained unusually firm: surveys consistently show low support for legalization compared to other G7 nations, and mainstream political discussion of recreational reform is essentially nonexistent as of 2025. The 2023 reform was framed almost entirely as a medical access measure and a tightening of enforcement, not as a step toward liberalization ^[3][7].

Disclaimer

This article is informational and is not legal advice. Cannabis law in Japan has changed materially in the last two years and may change further. If you face a legal question, consult a licensed Japanese attorney (bengoshi) or your embassy's consular section.

Information last verified: June 2025. For current statutes, see the Ministry of Health, Labour and Welfare and the e-Gov law database.

Sources

How this page was made